Fatty Liver Disease (MASLD/MASH): Symptoms, Staging, FIB-4 Score, and Reversal Strategies
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD, formerly NAFLD) affects over 30% of global adults. Learn how hepatic steatosis progresses to inflammatory MASH, how non-invasive scores (FIB-4) assess fibrosis, and how clinical lifestyle interventions can completely reverse early liver fat accumulation.
